checkAd
    Startseite > Aktien > Eledon Pharmaceuticals > Nachrichten
    Eledon Pharmaceuticals Aktie
    2,3100
     
    USD
    -3,75 %
    -0,0900 USD
    Letzter Kurs 11.05.24 Nasdaq
    2,2600
     
    USD
    900 STK
    Geldkurs 10.05.24
    2,3100
     
    USD
    1.900 STK
    Briefkurs 10.05.24
    ISIN: US28617K1016 · WKN: A2QL00 · SYM: ELDN · USA

    Neueste Nachrichten

    Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results
    09.05.24 · globenewswire · Eledon Pharmaceuticals
    Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Transplant Congress
    09.05.24 · globenewswire · Eledon Pharmaceuticals
    Eledon Announces Clinical Progress with Tegoprubart in the Prevention of Transplant Rejection
    07.05.24 · globenewswire · Eledon Pharmaceuticals
    Eledon Pharmaceuticals Announces Oversubscribed $50 Million Private Placement
    07.05.24 · globenewswire · Eledon Pharmaceuticals
    Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results
    28.03.24 · globenewswire · Eledon Pharmaceuticals
    Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection
    25.03.24 · globenewswire · Eledon Pharmaceuticals
    Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human
    21.03.24 · globenewswire · Eledon Pharmaceuticals
    Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    14.02.24 · globenewswire · Eledon Pharmaceuticals
    Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2024 Outlook
    04.01.24 · globenewswire · Eledon Pharmaceuticals
    Eledon Pharmaceuticals to Present at Noble Capital Markets' Emerging Growth Equity Conference
    29.11.23 · globenewswire · Eledon Pharmaceuticals
    Eledon Pharmaceuticals Reports Third Quarter 2023 Operating and Financial Results
    09.11.23 · globenewswire · Eledon Pharmaceuticals
    Eledon Reports Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation
    02.11.23 · globenewswire · Eledon Pharmaceuticals